Exagen Inc. to Participate in Upcoming Investor Conferences
Globe Newswire•29/10/2026•09:00 ET
0
Key Highlights
- ➤Exagen (XGN) management to meet investors at two November conferences
- ➤Canaccord Genuity forum panel scheduled for November 11, 2026, at 10:30am ET
- ➤Craig-Hallum Alpha Select Conference participation scheduled for November 17, 2026
CARLSBAD, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, today announced that management will participate in and meet with investors at the following investor conferences:
Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum – New York, NY
Get started
Create a free account to read the full story.